Latest news with #MedicalTechnology
Yahoo
3 days ago
- Business
- Yahoo
Medical Technology Platform Market Poised for Significant Growth, Forecast to Hit USD 67.26 Billion by 2032, Says Coherent Market Insights
Burlingame, CA, Aug. 08, 2025 (GLOBE NEWSWIRE) -- The global Medical Technology Platform Market is estimated to be valued at USD 31.59 Bn in 2025 and is expected to reach USD 67.26 Bn in 2032, exhibiting a compound annual growth rate (CAGR) of 11.4% from 2025 to 2032. The medical technology platform market is experiencing rapid growth, driven by the integration of advanced technologies such as artificial intelligence, cloud computing, Internet of Medical Things (IoMT), and big data analytics. These platforms enable seamless healthcare delivery through telemedicine, remote patient monitoring, diagnostics, and personalized treatment solutions. Trends such as interoperability, predictive analytics for disease management, and patient-centric digital ecosystems are reshaping the healthcare landscape. Rising demand for connected, data-driven care, coupled with regulatory support and the push for value-based healthcare, is positioning the medical technology platform market as a key driver of future medical innovation and efficiency. Request Sample Copy: Global Medical Technology Platform Market Key Takeaways According to Coherent Market Insights (CMI), the global medical technology platform market size is expected to grow more than 2.1X during the forecast period, increasing from USD 31.59 Bn in 2025 to USD 67.26 Bn by 2032. Global demand for medical technology platforms is projected to rise at a CAGR of 11.4% during the assessment period. Cardiovascular segment is set to remain the most lucrative application area for medical technology platforms, capturing a prominent 23% market share in 2025 North America is likely to maintain its dominant position during the assessment period, accounting for over two-fifths of the global medical technology market share in 2025. Europe is poised to remain the second-leading market for medical technology platforms, capturing a global market share of 28.8% in 2025. Asia Pacific is anticipated to emerge as a hotbed for medical technology platform companies during the assessment period. Rising Demand for Digital Healthcare Solutions Spurring Market Growth Coherent Market Insights' latest medical technology market analysis outlines key factors driving industry growth. Increasing demand for digital healthcare solutions is one such growth driver. Patients and healthcare providers in the contemporary world demand seamless digital experiences. This is driving adoption of telemedicine, remote monitoring, and mobile health apps, thereby fostering growth of the medical technology platform market. There is also an increasing need for interoperability across healthcare systems. This trend is fueling adoption of medical technology platforms that consolidate electronic health records (EHRs), diagnostics, imaging, and telemedicine. Purchase Now Up to 25% Discount on This Premium Report: High Cost and Data Security Concerns Restraining Market Growth The future medical technology platform market outlook appears promising. However, high cost of medical devices and growing concerns over data security may limit market growth to some extent during the forecast period. Advanced medical technologies like robotic surgical systems, implantable devices, and imaging tools are quite expensive. This cost factor deters their adoption, leading to reduced medical technology platform market demand. Moreover, growing digitalization of healthcare raises risks of cyberattacks and data breaches. These security concerns might also limit adoption during the forthcoming period, potentially restricting the medical technology platform market growth. Rising Incidence of Chronic Diseases Creating Lucrative Growth Opportunities The global incidence of chronic conditions like diabetes, cancer, cardiovascular diseases, and neurological disorders is steadily increasing. This growing burden is expected to drive demand for advanced diagnostic, monitoring, and therapeutic platforms, thereby creating significant growth opportunities in the medical technology platform industry. There is also increasing demand for improved patient care, including earlier and more accurate diagnosis, personalized treatments, and better recovery outcomes. This is fueling need for medical technology platforms, as they support these goals by providing advanced tools for monitoring, diagnosis, and intervention. Impact of AI on the Medical Technology Platform Market Artificial Intelligence (AI) is becoming a powerful tool in the medical technology platform market. It enhances diagnostic accuracy, optimizes clinical workflows, and enables predictive analytics. AI-powered platforms are revolutionizing areas like imaging, patient monitoring, and personalized treatment planning by delivering faster, data-driven insights. These innovations improve operational efficiency, reduce human error, and support real-time decision-making, ultimately driving better patient outcomes. Companies like Medtronic, GE Healthcare, and Philips lead from the forefront when it comes to AI adoption. For instance, in April 2024, Medtronic launched 14 new AI‑driven algorithms for its Touch Surgery™ Performance Insights platform. These algorithms span surgical workflow optimization, instrument recognition, and anatomical structure detection, enhancing AI-powered post‑operative analysis for various procedures. Emerging Medical Technology Platform Market Trends Expansion of telehealth and remote patient monitoring is a key growth-shaping trend in the medical technology platform market. The COVID-19 pandemic significantly accelerated the adoption of remote healthcare services. This shift has increased the demand for robust, interoperable, and scalable medical technology platforms that can support virtual consultations, real-time health monitoring, and data integration. Another notable trend is the growing demand for personalized medicine. Medical technology platforms support this shift by enabling genomic data analysis, personalized treatment planning, and biomarker discovery, which are essential components of precision medicine. There is a growing shift towards preventive care and home-based healthcare. This trend is fueling demand for at-home diagnostic tools, wearable health devices, and remote patient monitoring solutions that support proactive and continuous health management. Governments and regulatory bodies across different regions are promoting or mandating the use of electronic health records (EHRs). This is expected to create a fertile ground for the growth of medical technology platform industry during the forecast period. Ongoing technological advancements are driving the popularity and adoption of medical technology platforms. Companies are increasingly integrating AI and machine learning (ML) into these platforms to enhance diagnostics, enable predictive analytics, and support personalized treatment, thereby fueling market growth. Request For Customization: Analyst's View said Komal Dighe, a senior analyst at CMI. Current Events and Their Impact on the Medical Technology Platform Market Event Description and Impact Generative & Clinical AI Expanding Inside Healthcare Platforms Description: Cedars‑Sinai Connect, launched in collaboration with K Health, has served over 42,000 patients, automating intake, preliminary diagnosis, and triage via chatbot interfaces, delivering AI recommendations rated optimal ~77% of the time versus 67% for physicians. Impact: This highlights the strong demand for tightly integrated AI capabilities in diagnostics, patient intake, and automated documentation. Remote Monitoring, Digital Twin & IoMT Integration Description: At SGPGI in India, digital twin tools powered by AI are being used to simulate and optimize surgical outcomes using patient-specific hemodynamic data, pioneering safer, personalized care in a resource‑stretched setting. Impact: This highlights a need for platforms that can integrate IoMT wearables, support real-time data modeling, and simulate outcomes via interoperable digital twin frameworks. Healthcare Cyberattacks & Zero‑Trust Driving Security‑First Platforms Description: The healthcare sector saw a staggering 1,710 security incidents in 2025. Impact: There is an increasing pressure to adopt zero-trust architectures, end-to-end encryption, and resilient backup systems within medtech platforms. Competitor InsightsKey companies in the medical technology platform market research report: GE Healthcare Philips Medtronic Stryker Canon Medical Systems Abbott Siemens Healthineers Boston Scientific Baxter Johnson & Johnson Key Developments In April 2025, Royal Philips unveiled its new groundbreaking Elevate Platform upgrade on the EPIQ Elite ultrasound imaging platform. This new solution is designed to address the growing demand for greater diagnostic efficiency and streamlined workflows. In April 2025, SPARK Radiology launched a new AI-powered technology platform named in India. The platform is specifically developed to streamline radiology reporting workflows, reduce manual workload, enable faster report turnaround times, and ultimately support more accurate and timely diagnoses. In September 2024, Huawei launched the 'Medical Technology Digitalization 2.0 Solution' during its HUAWEI CONNECT 2024 event in Shanghai. The solution utilizes AI-assisted diagnosis and intelligent quality control, with dual goals of facilitating precision healthcare and supporting hierarchical diagnosis and treatment systems. Market Segmentation:Medical Technology Market, By Product TypeDiagnostic PlatformsMonitoring PlatformsSurgical PlatformsImplantable Devices PlatformsOthersMedical Technology Market, By ApplicationCardiovascularOrthopedicsNeurologyRespiratoryOncologyOthersMedical Technology Market, By End UserHospitalsClinicsDiagnostic CentersAmbulatory Surgical CentersOthersMedical Technology Market, By RegionNorth AmericaEuropeAsia PacificLatin AmericaMiddle East and Africa Read More Reports:Digital Medicines Market Size, Share & Trend Analysis Report for 2025-2032Integrated Patient Care Systems Market Size, Share, Trends & Opportunities for 2025-2032Digital Health Monitoring Devices Market Analysis and Forecast for 2025-2032 Our Trusted Partners:Worldwide Market Reports, Coherent MI, Stratagem Market InsightsGet Recent News: CONTACT: About Us: Coherent Market Insights leads into data and analytics, audience measurement, consumer behaviors, and market trend analysis. From shorter dispatch to in-depth insights, CMI has exceled in offering research, analytics, and consumer-focused shifts for nearly a decade. With cutting-edge syndicated tools and custom-made research services, we empower businesses to move in the direction of growth. We are multifunctional in our work scope and have 450+ seasoned consultants, analysts, and researchers across 26+ industries spread out in 32+ countries. Contact Us: Mr. Shah Coherent Market Insights 533 Airport Boulevard, Suite 400, Burlingame, CA 94010, United States US: + 12524771362 UK: +442039578553 AUS: +61-2-4786-0457 India: +91-848-285-0837 Email: sales@ Website: For Latest Update Follow Us: LinkedIn | Facebook | TwitterSign in to access your portfolio
Associated Press
29-07-2025
- Business
- Associated Press
Xtant Medical Partners With B2i Digital to Educate Investors on Its Orthobiologics Innovation and Market Opportunity
The Partnership Will Deliver Centralized, Investor-focused Content to Help Retail and Institutional Audiences Gain Insight Into Xtant's Orthobiologics Platform and Long-term Value Proposition NEW YORK, NY - July 28, 2025 ( NEWMEDIAWIRE ) - B2i Digital is pleased to announce that Xtant Medical Holdings (NYSE American: XTNT) has been named a B2i Digital Featured Company. Xtant is a global medical technology company that develops, manufactures, and markets a full-service portfolio of regenerative medicine products and related medical devices for orthopedic and neurosurgical specialists. The company's vertically integrated model allows it to offer a full-service product line that includes bone-healing grafts, growth-factor biologics, cellular allografts, synthetics, and amnion products. This integration, combined with a robust R&D pipeline that includes multiple next-generation biologics scheduled for launch through 2025, underpins its strategy for driving margin improvement and long-term, sustainable growth. 'We are pleased to showcase Xtant Medical to our investor community at this pivotal time in the company's expansion and evolution,' said David Shapiro, CEO of B2i Digital. 'With its vertically integrated platform covering all five major orthobiologic categories and a clear trajectory of revenue growth, the company presents a compelling story for investors interested in the medical technology sector. Xtant's established distribution network and robust product pipeline position it well within a multi-billion-dollar market.' Sean Browne, CEO of Xtant Medical, commented, 'Our partnership with B2i Digital will help us share our growth story and the value of our comprehensive biologics platform to the investment community. We are focused on execution and believe this collaboration will enhance our connection with current and prospective shareholders.' Xtant Medical has demonstrated strong business fundamentals, reporting fiscal year 2024 revenue of $117.5 million, a 29% year-over-year increase. The company has established significant market access through 450 integrated delivery network (IDN) contracts and a network of over 670 independent distributors, serving a $2.5 billion U.S. orthobiologics market within a $10.1 billion global spine market. About B2i Digital, Inc. B2i Digital, Inc. partners with investor conferences, public companies, and capital markets advisors through its Featured Conference, Featured Company, and Featured Expert programs. The firm leverages digital marketing technologies, a network of 1.3 million investors, and targeted introductions to connect key players in the markets. B2i Digital was founded in 2021 by David Shapiro, previously the Chief Marketing Officer and an investment banker at Maxim Group, LLC. David was also one of the founders of Maxim's investor awareness platform, B2i Digital Contact Information: David Shapiro Chief Executive Officer B2i Digital, Inc. 212.579.4844 Office [email protected] About Xtant Medical Holdings, Inc. Xtant Medical's mission of honoring the gift of donation so that our patients can live as full and complete a life as possible, is the driving force behind our company. Xtant Medical Holdings, Inc. ( ) is a global medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Xtant people are dedicated and talented, operating with the highest integrity to serve our customers. Investor Contact Information: Kevin Gardner Managing Director LifeSci Advisors 646.889.1200 [email protected] View the original release on
Globe and Mail
24-07-2025
- Business
- Globe and Mail
Hologic's International Momentum Takes Shape: Will Execution Pay Off?
International expansion continues to play a central role in Hologic 's HOLX growth strategy. Currently, it generates around 25% of its total revenues from outside the United States — a lower proportion compared to other medical technology companies. Over the past decade, the company has made targeted investments toward international expansion and commercial capabilities, which have delivered more than 10% international growth annually. Even so, the underpenetration presents significant room for expansion. While many of Hologic's product successes began in the United States, it has now built the capabilities to scale internationally on a consistent basis. In its Surgical division, the company continues to invest organically, especially in the International business, where it has delivered more than 20% growth for several years. The momentum is supported by increased reimbursement and the promotion of guidelines for its portfolio of product offerings. In the fiscal second quarter of 2025, the International Surgical business rose 16.2% year over year. MyoSure is seeing even faster gains abroad, fueled by vastly untapped markets and higher demand for minimally invasive options to treat uterine polyps and fibroids. Newly acquired Gynesonics gave a boost, having already generated a healthy mix of international sales before joining Hologic. Now with the support of Hologic's large Gyn sales force, Gynesonics' sales are expected to grow at a strong double-digit rate. NovaSure is also seeing higher sales volume in Europe despite posting domestic declines. That said, global exposure brings added operational challenges. The company's second-quarter international sales were hurt by the ongoing physician strike in South Korea, reduced hospital spending in China and lower HIV testing sales in Africa due to USAID funding cuts. In China, Hologic's cytology business is now weighed down by tariff implications, anti-American sentiment and intensifying local competition. International Performance of Hologic's Top Rivals Becton, Dickinson and Company BDX, or BD, derives a significant portion of its revenues from overseas, with products being distributed either directly or through independent distribution channels and sales representatives. In the second quarter of 2025, BD's international revenues increased 1.2%, driven by gains in the Medical segment's Pharmaceutical Systems unit and the acquired Advanced Patient Monitoring unit's sales. Based on tariffs in effect as of April 30, 2025, BD anticipates a $90 million hit to fiscal year 2025 operating expenses. Abbott ABT, too, maintains a strong global footprint, with sales outside the United States accounting for approximately 61% of its 2024 net sales. In the second quarter of 2025, international sales increased 6.6% year over year. Abbott remains the global leader in adult nutrition, supported by continued demand for its Ensure and Glucerna brands. ABT's Electrophysiology division also drove strong performance across 15 key markets — including India, China, and other markets across Asia, Latin America and the Middle East — representing some of the most attractive growth areas for branded generic medicines. HOLX Stock Performance, Valuation and Estimates Year to date, Hologic shares have declined 8.5% compared with the industry's 10.2% fall. Image Source: Zacks Investment Research Hologic is trading at a forward five-year price-to-earnings of 14.84X, lower than the industry average of 28.28X. The stock carries a Value Score of B at present. Image Source: Zacks Investment Research Consensus estimates for Hologic's fiscal 2025 EPS are showing a downward trend for the past 90 days. Image Source: Zacks Investment Research HOLX stock currently carries a Zacks Rank #4 (Sell). You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here. 7 Best Stocks for the Next 30 Days Just released: Experts distill 7 elite stocks from the current list of 220 Zacks Rank #1 Strong Buys. They deem these tickers "Most Likely for Early Price Pops." Since 1988, the full list has beaten the market more than 2X over with an average gain of +23.5% per year. So be sure to give these hand picked 7 your immediate attention. See them now >> Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Abbott Laboratories (ABT): Free Stock Analysis Report Becton, Dickinson and Company (BDX): Free Stock Analysis Report Hologic, Inc. (HOLX): Free Stock Analysis Report
Yahoo
17-07-2025
- Business
- Yahoo
Pharmaceutical Packaging Equipment Market worth $14.3 billion by 2030 with 6.3% CAGR
DELRAY BEACH, Fla., July 17, 2025 /PRNewswire/ -- The global Pharmaceutical Packaging Equipment Market, valued at US$ 9.75 billion in 2024 stood at US$10.5 billion in 2025 and is projected to advance at a resilient CAGR of 6.3% from 2025 to 2030, culminating in a forecasted valuation of US$14.3 billion by the end of the period. The pharmaceutical packaging equipment market is rapidly growing due to the increasing demand for accurate and high-quality diagnostic imaging, fueled by a rise in chronic diseases and an aging population. Advances in display technology, such as higher resolutions and improved color accuracy, enhance diagnostic precision. Furthermore, the growing adoption of digital healthcare systems, telemedicine, and minimally invasive surgeries is also boosting demand. Increased healthcare spending and investments in medical infrastructure worldwide contribute significantly to the market's sustained growth. In this report, the market is divided into product, formulation, automation, end user, and region. Download PDF Brochure: Browse in-depth TOC on "Pharmaceutical Packaging Equipment Market" 361 - Tables57 - Figures404 - Pages By product, Primary packaging equipment plays a crucial role in the pharmaceutical industry, holding the largest market share due to its direct impact on safeguarding the integrity, sterility, and efficacy of various drug formulations. This equipment is essential for an array of dosage forms, including tablets, liquids, and injectables, where maintaining the quality and safety of the product is paramount. One of the key functions of primary packaging is to ensure that pharmaceuticals comply with stringent regulatory standards set by health authorities. This compliance is vital not only for consumer safety but also for the approval processes that allow drugs to enter the market. As the demand for unit-dose formats continues to rise, driven by both patient convenience and the need for accurate dosing, the adoption of advanced primary packaging solutions has surged. Moreover, these advancements are becoming increasingly important in high-throughput packaging environments, where efficiency and speed are critical to meet the growing demands of both generic and branded pharmaceutical production lines. This evolution in packaging technology is helping manufacturers optimize their operations while ensuring that the products maintained within these packages meet the highest standards of quality and effectiveness. Overall, the landscape of primary packaging equipment is shaped by the dual pressures of regulatory compliance and market demand, leading to widespread innovation and adoption across the pharmaceutical sector. By formulation, Liquid packaging equipment dominates the market, primarily because of the increasing demand for various liquid pharmaceuticals, including syrups, injectables, eye drops, and vaccines. These products necessitate sophisticated packaging solutions that ensure precise, sterile filling and airtight sealing, which is crucial for maintaining product integrity and safety. The precision required in the packaging process is driving many companies to adopt advanced automated systems that enhance efficiency and accuracy. Additionally, there is a growing regulatory focus on contamination-free packaging within the pharmaceutical sector. Regulatory bodies are emphasizing the importance of non-contaminated packaging processes to safeguard public health, which in turn accelerates the demand for high-speed liquid packaging lines that integrate automation and cutting-edge technology. As a result, pharmaceutical manufacturing facilities are increasingly investing in these automated solutions to comply with strict regulations while ensuring production efficiency and reliability. This trend underscores the vital role that liquid packaging equipment plays in meeting the needs of a rapidly evolving pharmaceutical landscape. By geography, Europe dominates the pharmaceutical packaging equipment market, primarily due to its robust pharmaceutical manufacturing infrastructure, stringent regulatory landscape, and proactive integration of advanced automation technologies. Key players are concentrated in countries like Germany, Switzerland, and Italy, which host major pharma equipment manufacturers and significant global drug producers, resulting in a highly efficient supply chain. The stringent compliance requirements set forth by the EU Good Manufacturing Practices (EU-GMP), the Falsified Medicines Directive (FMD), and serialization mandates have driven the need for high-precision packaging systems that meet regulatory standards. Furthermore, the region's increasing investment in research and development, particularly in biologics and contract manufacturing, along with a strong focus on quality assurance and traceability, solidifies Europe's preeminence in the pharmaceutical packaging equipment sector. Request Sample Pages : The prominent players in the global pharmaceutical packaging equipment market are Syntegon Technology GmbH (Germany), Industria Macchine Automatiche (IMA) S.p.A (Italy), Körber AG (Germany), Coesia S.p. A. (Italy), Marchesini Group S.p.A (Italy), Bausch+Ströbel (Germany), Maschinefabrik Ilshofen GmbH+Co. KG (Germany), Romaco Group (Germany), Uhlmann (Germany), Maquinaria Industries Dara, SL (US). Syntegon Technology GmbH (Germany): Syntegon Technology GmbH has established itself as a leading provider in the pharmaceutical packaging industry, offering a wide array of robust solutions tailored to meet the diverse needs of the sector. The company excels in the design, manufacturing, marketing, and distribution of cutting-edge technologies that significantly improve mobility and efficiency in industrial applications. One of the core areas of Syntegon's expertise lies in sophisticated drive and control systems, which empower machinery to operate with precision and reliability. Their advanced packaging technologies are specifically engineered for the pharmaceutical sector, ensuring that products are securely packaged while maintaining compliance with stringent regulations. In addition to pharmaceutical solutions, Syntegon has expanded its offerings to include innovative packaging solutions for consumer goods, catering to a broader market with a focus on sustainability and user experience. The company also emphasizes energy management systems that optimize energy use and reduce waste, contributing to environmentally friendly manufacturing processes. Furthermore, Syntegon integrates building technology solutions that enhance operational efficiency within production facilities, seamlessly combining each element to create a holistic approach to industrial packaging. This comprehensive portfolio positions Syntegon Technology GmbH as a key partner for businesses looking to leverage technological advancements in packaging and production. Industria Macchine Automatiche (IMA) S.p.A (Italy) Industria Macchine Automatiche (IMA) S.p.A specializes in a diverse array of primary and secondary packaging equipment, designed to meet the varied needs of different industries, particularly pharmaceuticals. Over the past several years, the company has experienced a consistent upward trend in total revenue, largely driven by a substantial increase in the demand for its packaging solutions tailored for pharmaceutical products. This growth is attributed to the rising global emphasis on healthcare and the need for reliable packaging solutions that ensure product safety and integrity. The company has established extensive sales and distribution networks that reach more than 80 countries worldwide, enabling it to effectively cater to a broad customer base. To support its global operations, IMA operates several state-of-the-art manufacturing facilities located in key regions, including Italy, Germany, France, Switzerland, Spain, the United Kingdom, the United States, India, Malaysia, China, and Argentina. This strategic geographical distribution of production sites not only enhances the company's ability to meet local demand but also optimizes operational efficiencies. To maintain its competitive edge in the rapidly evolving packaging market and strategically increase its market share, the company is actively pursuing acquisitions. By broadening its product portfolio through these acquisitions, the company aims to diversify its offerings and enhance its technological capabilities, while also expanding its presence in emerging markets and established regions alike. This proactive approach positions the company to better respond to changing customer needs and industry trends. Korber AG (Germany) Körber AG - is a prominent player in the pharmaceutical packaging industry, renowned for its development and provision of cutting-edge technologies. The company specializes in a range of offerings, including advanced standard packaging systems and inspection machines that ensure the quality and safety of pharmaceutical products. In addition, Körber AG provides comprehensive track and trace solutions that enhance supply chain transparency and regulatory compliance, as well as tailored systems designed for patient-specific pharmaceutical solutions, catering to the growing demand for personalized medication. With a robust distribution network spanning the Americas, Europe, and Asia, Körber AG has successfully established itself in multiple markets. However, its presence in Latin America, a region identified as a high-growth market for pharmaceutical packaging equipment, remains relatively limited. This geographic gap presents both challenges and opportunities for the company as it seeks to expand its footprint in this promising area. Furthermore, Körber AG's approach to innovation has room for enhancement, as the company exhibits a constrained focus on new product developments. This limitation could potentially hinder its competitiveness in an industry that thrives on technological advancements and evolving customer needs. Nevertheless, the company has strategically pursued inorganic growth through acquisitions, which has significantly bolstered its market position. This strategy has enabled Körber AG to establish a stronghold in various segments of the industry, providing long-term benefits and ensuring adaptability in a rapidly changing marketplace. By continuing to leverage acquisitions while enhancing its focus on innovation, Körber AG can position itself more favorably in the competitive landscape of pharmaceutical packaging. For more information, Inquire Now! Related Reports: Active Pharmaceutical Ingredient Market Pharmaceutical Drying Equipment Market Empty Capsules Market Pharmaceutical Metal Detector Market Pharmaceutical Contract Manufacturing Market Get access to the latest updates on Pharmaceutical Packaging Equipment Companies and Pharmaceutical Packaging Equipment Market Size About MarketsandMarkets™: MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report. MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe. Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem. The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing. Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts. To find out more, visit or follow us on Twitter, LinkedIn and Facebook. Contact:Mr. Rohan SalgarkarMarketsandMarkets™ INC.1615 South Congress 103, Delray Beach, FL 33445USA: +1-888-600-6441Email: sales@ Our Website: Logo: View original content: SOURCE MarketsandMarkets Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
05-06-2025
- Business
- Yahoo
Intravascular lithotripsy: market competition and clinical potential: new issue of Medical Technology out now
The field of Intravascular lithotripsy (IVL), a medical procedure that uses ultrasound shockwaves to break down calcified plaque in arteries, particularly those in the coronary arteries or peripheral arteries, is generating increasing levels of interest. This month's cover feature looks at the clinical promise IVL holds beyond the financial buzz it has generated in recent times. This issue also features analyst comment on the impact Trump's tariffs are having on the medical device industry, with companies moving to stockpile equipment in certain areas. Don't miss our two interviews out of Biomed 2025, which recently took place in Tel Aviv, Israel in May, with each featuring insight into how the bioconvergence and neuromodulation markets are continuing to develop globally. All this and the latest medtech industry news, comment, and analysis from GlobalData. If you like our magazine, sign up to have each issue delivered to your inbox. "Intravascular lithotripsy: market competition and clinical potential: new issue of Medical Technology out now" was originally created and published by Medical Device Network, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site.
